These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11310595

  • 1. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands.
    Prisinzano T, Law H, Dukat M, Slassi A, MaClean N, Demchyshyn L, Glennon RA.
    Bioorg Med Chem; 2001 Mar; 9(3):613-9. PubMed ID: 11310595
    [Abstract] [Full Text] [Related]

  • 2. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
    Law H, Dukat M, Teitler M, Lee DK, Mazzocco L, Kamboj R, Rampersad V, Prisinzano T, Glennon RA.
    J Med Chem; 1998 Jun 18; 41(13):2243-51. PubMed ID: 9632357
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F, Guiblin AR, Jelley RA, Matassa VG, Reeve AJ, Hunt PA, Beer MS, Heald A, Stanton JA, Sohal B, Watt AP, Street LJ.
    J Med Chem; 1999 Feb 25; 42(4):677-90. PubMed ID: 10052975
    [Abstract] [Full Text] [Related]

  • 4. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
    Doménech T, Beleta J, Palacios JM.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep 25; 356(3):328-34. PubMed ID: 9303569
    [Abstract] [Full Text] [Related]

  • 5. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
    Pauwels PJ, Tardif S, Palmier C, Wurch T, Colpaert FC.
    Neuropharmacology; 1997 Sep 25; 36(4-5):499-512. PubMed ID: 9225275
    [Abstract] [Full Text] [Related]

  • 6. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
    Chambers MS, Street LJ, Goodacre S, Hobbs SC, Hunt P, Jelley RA, Matassa VG, Reeve AJ, Sternfeld F, Beer MS, Stanton JA, Rathbone D, Watt AP, MacLeod AM.
    J Med Chem; 1999 Feb 25; 42(4):691-705. PubMed ID: 10052976
    [Abstract] [Full Text] [Related]

  • 7. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, Van Gompel P, Wouters R, Lesage AS.
    Mol Pharmacol; 1996 Dec 25; 50(6):1567-80. PubMed ID: 8967979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.
    Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Göthert M, Jones BJ, Roberts C, Watson JM, Middlemiss DN.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep 25; 356(3):312-20. PubMed ID: 9303567
    [Abstract] [Full Text] [Related]

  • 10. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
    Lesage AS, Wouters R, Van Gompel P, Heylen L, Vanhoenacker P, Haegeman G, Luyten WH, Leysen JE.
    Br J Pharmacol; 1998 Apr 25; 123(8):1655-65. PubMed ID: 9605573
    [Abstract] [Full Text] [Related]

  • 11. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
    Wurch T, Colpaert FC, Pauwels PJ.
    Mol Pharmacol; 1998 Dec 25; 54(6):1088-96. PubMed ID: 9855638
    [Abstract] [Full Text] [Related]

  • 12. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
    Slassi A.
    Curr Top Med Chem; 2002 Jun 25; 2(6):559-74. PubMed ID: 12052194
    [Abstract] [Full Text] [Related]

  • 13. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.
    Bourrain S, Neduvelil JG, Beer MS, Stanton JA, Showell GA, MacLeod AM.
    Bioorg Med Chem Lett; 1999 Dec 06; 9(23):3369-74. PubMed ID: 10612601
    [Abstract] [Full Text] [Related]

  • 14. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E, Fink K, Molderings GJ, Price GW, Duckworth M, Gaster L, Middlemiss DN, Zentner J, Likungu J, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep 06; 356(3):321-7. PubMed ID: 9303568
    [Abstract] [Full Text] [Related]

  • 15. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ, Curtis MJ.
    Br J Pharmacol; 1997 Nov 06; 122(5):875-84. PubMed ID: 9384503
    [Abstract] [Full Text] [Related]

  • 16. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
    Perez M, Jorand-Lebrun C, Pauwels PJ, Pallard I, Halazy S.
    Bioorg Med Chem Lett; 1998 Jun 02; 8(11):1407-12. PubMed ID: 9871775
    [Abstract] [Full Text] [Related]

  • 17. 5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structure-affinity relationships for h5-HT1B and h5-HT1D receptors.
    Barf T, Wikström H, Pauwels PJ, Palmier C, Tardif S, Lundmark M, Sundell S.
    Bioorg Med Chem; 1998 Sep 02; 6(9):1469-79. PubMed ID: 9801818
    [Abstract] [Full Text] [Related]

  • 18. Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors.
    Zgombick JM, Bard JA, Kucharewicz SA, Urquhart DA, Weinshank RL, Branchek TA.
    Neuropharmacology; 1997 Sep 02; 36(4-5):513-24. PubMed ID: 9225276
    [Abstract] [Full Text] [Related]

  • 19. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
    Classey JD, Bartsch T, Goadsby PJ.
    Brain Res; 2010 Nov 18; 1361():76-85. PubMed ID: 20833155
    [Abstract] [Full Text] [Related]

  • 20. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
    Newman-Tancredi A, Cussac D, Audinot V, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun 18; 359(6):447-53. PubMed ID: 10431754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.